Page 1242 - Small Animal Clinical Nutrition 5th Edition
P. 1242

1294 SMALL ANIMAL CLINICAL NUTRITION



                  Index
        VetBooks.ir



                  Page numbers followed by t indicate tables; f, figures,   loss, 529f
                  b, boxes, c, cases, a, appendices.                    stabilizing body weight after weight loss, 530f
                                                                      Alkaline tide, effects on urine, 380, 380f, 385t, 823, 960, 960f,
                  A                                                     965-966, 1200
                  AAFCO, nutrient profiles as allowances, 8           Alkalinization, of urine
                  Accommodation, 441-446                                for management of ammonium urate urolithiasis, 840, 842,
                  ACE inhibitors                                        847
                    interactions in patients with cardiovascular disease, 735-  for management of cystine urolithiasis, 886, 888
                    737, 746t, 749, 750t, 752, 753-755, 758c            role of pet food ingredients, 935t, 951b
                    interactions in patients with chronic kidney disease, 780t,  Allergy (See Atopy, Adverse food reactions)
                    782t, 790, 799, 808-810c                          Allopurinol, use in patients with urolithiasis, 833, 836, 837f,
                  Acetate, 68t, 74-76, 76f, 127, 365-366, 1222          839-847, 841t, 843b, 844f, 846t, 848-851c, 851-853c, 868,
                  Acetohydroxamic acid, 897t, 898, 901-902, 904         929, 943
                  Acidification, of urine, 432, 678b, 878, 884, 896-897, 902,  All-purpose foods, as marketing concept, 162
                    904, 920, 942b, 947f, 964, 1200                   Alopecia, 94, 103, 108t, 412-413c, 572t, 611, 638t, 646-647,
                  Activity product, in urolithiasis, 816, 818, 825t, 941b, 942,  652, 1173, 1210c, 1231
                    952, 965                                          Alpha-linolenic (α-linolenic) acid, 263, 286, 301, 383, 408,
                    vs. relative supersaturation, 941b, 952t, 953f, 965  431, 643, 653t, 654t, 700, 748
                  Acute gastroenteritis and enteritis, 1053-1063      American College of Veterinary Nutrition (ACVN), 4
                    assessment of, 1053-1055                          Amino acids (See also Protein)
                    breed-associated small intestinal disorders, 1049t  aromatic amino acids, 1164b, 1166-1167, 1167t
                    clinical importance of, 1053                        branched-chain amino acids, 698b, 787b, 1164b, 1166,
                    clinical signs of life-threatening, 1054t           1166t, 1176
                    commercial foods for, 1057t, 1058t, 1059t, 1060t    essential amino acids, 82, 83t, 84t, 88, 91-95, 264, 477,
                    feeding plan for patients with, 1059-1061           483-484, 597, 1166, 1202, 1289
                    key nutritional factors for, 1055                   names of, 83t, 84t
                    risk factors for, 1054                              nonessential amino acids, 83t, 84t
                  Addiction, food, 170                                Aminoglycoside and nephrotoxicosis, 768, 1200, 1204, 1206
                  Additives, in pet food, 57, 165, 176-177, 193, 197, 203, 204t,  Ammonia
                    205-206, 208-209, 227, 700, 951                     increased associated with FLUTD, 942-943
                    adverse reactions to, 611, 616, 619, 619t, 625      metabolic acidosis and renal ammoniagenesis, 779, 783b
                  Ad libitum feeding, 17 (See Free-choice feeding)      production in struvite urolithiasis, 892-893
                  Adverse reactions to food, 609-635                    role in hepatic encephalopathy, 1160, 1164-1165b, 1166,
                    assessment, 610                                     1168-1169b, 1180b
                    classification of, 610f                           Ammonium urate/purine urolithiasis, in dogs, (See Canine
                    clinical importance of, 609-610                     purine urolithiasis)
                    dermatologic responses in cats, 611               Anagen, 642-643
                    dermatologic responses in dogs, 610               Anagen defluxion, 638t, 643
                    feeding plan, 619-623                             Angiotensin-converting enzyme inhibitors (See ACE
                    gastrointestinal responses, 611                     inhibitors)
                    immunologic reactions, 614, 614f                  Anorexia, 52b, 65, 108t, 123, 124t, 166t, 301b, 365b, 441-
                    key nutritional factors, 617-619, 617t              445, 443f, 571, 588, 589t, 987t, 1143, 1152-1153c, 1161,
                    nonimmunologic reactions, 616-617, 613f             1185-1187c, 1219f, 1226, 1235c, 1253-1254c
                    pathophysiologic mechanisms, 615-617              Antioxidants, 149-155
                    risk factors for, 613                               as food preservatives, 103, 149, 176t, 190, 209, 233
                  Aflatoxins, 230t, 232, 242-243c                       for protection against oxidative stress, 140
                  Aging pets, relationship to renal disease, 776      Antioxidant vitamins, use in patients with hepatobiliary dis-
                  Albumin, 81-97                                        ease (See also Antioxidants), 1162, 1164b, 1175, 1181b
                  Algorithms                                          Appendices
                    combined dietary and medical management for constipa-  Body surface area of cats, 1275
                    tion and obstipation, 1123f                         Body surface area of dogs, 1276
                    management of calcium oxalate uroliths in dogs, 867f  Body weights in kilograms and height at withers in cen-
                    management of struvite uroliths in cats, 963f       timeters of selected canine breeds, 1277
                    protocol for food elimination trials, 624f          Body weights in pounds and height at withers in inches of
                    route of nutritional support, 458f                  selected canine breeds, 1281
                    decision making and patient monitoring during weight  Comparison between U.S. and imperial systems, 1273
   1237   1238   1239   1240   1241   1242   1243   1244   1245   1246   1247